Phenanthridine

Phenanthridine

SCHEMBL460289

C.c1ccc2c(c1)cnc1ccccc12

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 3/20 0.95
KDM4E B2RXH2 2/20 0.95
CYP3A4 P08684 1/20 0.54
TOP2A P11388 1/20 0.49
CYP1A2 P05177 2/20 0.47
MAPT P10636 3/20 0.46
NPC1 O15118 1/20 0.46
LMNA P02545 1/20 0.46
RECQL P46063 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PDE10A Q9Y233 1/20 0.45
ADORA3 P0DMS8 1/20 0.44
ALDH1A1 P00352 1/20 0.43
CYP2A6 P11509 1/20 0.43
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PDPK1 O15530 1/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenanthridine SCHEMBL30914262 0.98 GPR3 (1.00) GPR3KDM4ECYP3A4TOP2ACYP1A2
Phenanthridine SCHEMBL30823553 0.98 GPR3 (1.00) GPR3KDM4ECYP3A4TOP2ACYP1A2
Phenanthridine SCHEMBL9106884 0.98 GPR3 (1.00) GPR3KDM4ECYP3A4TOP2ACYP1A2
Phenanthridine SCHEMBL8666 0.98 GPR3 (1.00) GPR3KDM4ECYP3A4TOP2ACYP1A2
Phenanthridine SCHEMBL23003530 0.95 GPR3 (0.95) GPR3KDM4ECYP3A4TOP2ACYP1A2
Phenanthridine SCHEMBL3702845 0.95 GPR3 (0.95) GPR3KDM4ECYP3A4TOP2ACYP1A2
Phenanthridine SCHEMBL2422346 0.95 GPR3 (0.95) GPR3KDM4ECYP3A4TOP2ACYP1A2
Phenanthridine SCHEMBL8505090 0.95 GPR3 (0.95) GPR3KDM4ECYP3A4TOP2ACYP1A2
Phenanthridine SCHEMBL2421052 0.95 GPR3 (0.95) GPR3KDM4ECYP3A4TOP2ACYP1A2
Phenanthridine SCHEMBL29754194 0.95 GPR3 (0.95) GPR3KDM4ECYP3A4TOP2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116924986-B Nitrogen-containing heterocycle functional layer material, preparation method and application 山东千铄新材料有限公司 2024-04-09 CN disclosed
CN-116924986-A Nitrogen-containing heterocycle functional layer material, preparation method and application 山东千铄新材料有限公司 2023-10-24 CN disclosed
US-8741917-B2 Benzo [C] phenanthridines as antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-03 US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 US disclosed
EP-2387564-A1 BENZO ÝC¨PHENANTHRIDINES AS ANTIMICROBIAL AGENTS Rutgers, The State University of New Jersey (US) 2011-11-23 EP disclosed
US-8037884-B2 Modular system for patient positioning during medical procedures ALLEN MEDICAL SYSTEMS, INC. (US) 2011-10-18 US disclosed
WO-2010083436-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS CCNT1, XPO4, XDH GPR3 3066/4885KDM4E 536/4885CYP3A4 131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.